Trinity Biotech (TRIB) announced that on November 6, 2024, it received written notice from the Nasdaq Stock Market confirming that the Company has regained compliance with the minimum market value of publicly held shares requirement under Nasdaq Listing Rule 5450(b)(2)(C) (the “MVPHS Requirement”).
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRIB:
- Trinity Biotech Acquires EpiCapture to Enter Oncology Market
- Trinity Biotech Invests in Rapid Sepsis Testing Innovation
- Trinity Biotech acquires 12.5% stake in Novus Diagnostics valued at $2.5M
- Trinity Biotech acquires EpiCapture for initial $3M consideration
- Trinity Biotech Advances in Diabetes Monitoring Tech